Agios Crashes 21% After A Surprise Side Effect Hammered Its 'Very Safe' Drug

Agios Crashes 21% After A Surprise Side Effect Hammered Its 'Very Safe' Drug

Submitted by admin on December 9, 2024 - 9:06pm
Source: 
Investors Business Daily
News Tags: 
Agios Pharmaceuticals
mitapivat
liver injury
thalassemia
Headline: 
Agios Crashes 21% After A Surprise Side Effect Hammered Its 'Very Safe' Drug
snippet: 

Shares of Agios Pharmaceuticals (AGIO) collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, mitapivat.

Do Not Allow Advertisers to Use My Personal information